Chargement en cours...
Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes
BACKGROUND: Postprandial hyperglycemia poses a challenge to closed-loop systems. Dipeptidyl peptidase-4 (DPP-4) inhibitors, like sitagliptin, reduce postprandial glucose concentrations in patients with type 2 diabetes. The objective of this study was to assess sitagliptin’s role in type 1 diabetes (...
Enregistré dans:
| Publié dans: | J Diabetes Sci Technol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5505438/ https://ncbi.nlm.nih.gov/pubmed/28349708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817699847 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|